about
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersPrediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationDes-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.Colorimetric immunoassay for detection of tumor markers.An increased standardised mortality ratio for liver cancer among polyvinyl chloride workers in Taiwan.Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinomaTransplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapyMeta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma.Establishment of an enzyme immunoassay using monoclonal antibody (HG1-219) and its application for the diagnosis of hepatocellular carcinoma.Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization.Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.Alpha-fetoprotein expression in hepatocellular carcinoma: a clinical study.Identification of lung adenocarcinoma specific dysregulated genes with diagnostic and prognostic value across 27 TCGA cancer types.Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients.Age-related, different clinicopathologic features of hepatocellular carcinoma patients
P2860
Q26741204-6166AD46-E112-448D-845D-AA77329AB6BCQ26772329-682F9902-1AB1-4D2C-8DBB-97928B451399Q31911652-F362C6FC-018B-4FC6-A779-01082642F8BCQ33935625-B8ECE35A-F028-4D16-B5B7-45A4FEBE8849Q34530671-9C88265B-C3AC-4C3F-B716-0179D7E2FD88Q35002196-9E47F7B1-FB94-4CA3-8146-7B76CCFE08E2Q35495849-15AFD08F-ECFA-471E-BF7D-EC71F2EC2855Q36081470-C6345EF3-A105-4993-8B4D-8FE0289B81ADQ37034067-0DAE89BC-ED55-4F7C-99DD-FB52763D76DBQ37197517-988AF9CB-64F4-4294-AE07-076FB7152A91Q41593276-43EB464F-F81C-40FC-AA9E-893E7C107B6FQ41907562-F37F93AB-D424-4849-A0DD-F9900D06F0A9Q42148828-A79EF931-192B-4BEA-8CF6-088F1A171573Q44617401-8AA7961C-528E-4C15-9FD0-7CBF4DD75A5EQ45244899-9C99A913-CD1F-402E-8CF3-41B2B201A38BQ46195024-98512E52-427F-4171-9BD9-50456F437076Q53454226-3AB8A378-7995-44C2-BD93-4844D33FA68CQ57000796-390BAFB4-B5CA-4E10-B064-4D20B0C22497
P2860
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Serum alphafetoprotein in hepatocellular carcinoma.
@en
Serum alphafetoprotein in hepatocellular carcinoma.
@nl
type
label
Serum alphafetoprotein in hepatocellular carcinoma.
@en
Serum alphafetoprotein in hepatocellular carcinoma.
@nl
prefLabel
Serum alphafetoprotein in hepatocellular carcinoma.
@en
Serum alphafetoprotein in hepatocellular carcinoma.
@nl
P1433
P1476
Serum alphafetoprotein in hepatocellular carcinoma.
@en
P304
P356
10.1002/1097-0142(197708)40:2<779::AID-CNCR2820400227>3.0.CO;2-Y
P407
P577
1977-08-01T00:00:00Z